B. Antonacci

Comparison of SCH 39304, fluconazole, and ketoconazole for treatment of systemic infections in mice

D. Loebenberg, F. Menzel, A. Cacciapuoti, 1992, Antimicrobial Agents and Chemotherapy.

Relationship Among Physicochemical Properties, Skin Permeability, and Topical Activity of the Racemic Compound and Pure Enantiomers of a New Antifungal

D. Loebenberg, I. Chaudry, A. Cacciapuoti, 2004, Pharmaceutical Research.

In Vitro and In Vivo Activities of SCH 56592 (Posaconazole), a New Triazole Antifungal Agent, againstAspergillus and Candida

D. Loebenberg, F. Menzel, A. Cacciapuoti, 2000, Antimicrobial Agents and Chemotherapy.

Sch 39304, a new antifungal agent: oral and topical treatment of vaginal and superficial infections.

D. Loebenberg, F. Menzel, A. Cacciapuoti, 1993, Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology.

In vitro and in vivo activities of SCH 42427, the active enantiomer of the antifungal agent SCH 39304

D. Loebenberg, F. Menzel, A. Cacciapuoti, 1992, Antimicrobial Agents and Chemotherapy.

Comparative in vitro and in vivo evaluation of N-D-ornithyl amphotericin B methyl ester, amphotericin B methyl ester, and amphotericin B

D. Loebenberg, P. Chiu, G. Miller, 1987, Antimicrobial Agents and Chemotherapy.

Comparative InVitro andInVivoEvaluation ofN-D-Ornithyl Amphotericin B MethylEster, Amphotericin B MethylEster, and Amphotericin B

B. Antonacci, R. Scupp, Schering-Plough Corp, 1987 .

Comparison ofSCH39304, Fluconazole, andKetoconazole for Treatment ofSystemic Infections inMice

A. Cacciapuoti, R. Parmegiani, B. Antonacci, 1992 .

Isobenzofurans as conformationally constrained miconazole analogues with improved antifungal potency.

H. Guzik, D. Loebenberg, A. J. Elliott, 1992, Journal of medicinal chemistry.

Discovery of a Novel Class of Orally Active Antifungal β-1,3-d-Glucan Synthase Inhibitors

R. J. Herr, P. Mann, S. Walker, 2011, Antimicrobial Agents and Chemotherapy.